共 223 条
[1]
Llovet JM(2008)Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 698-711
[2]
Di Bisceglie AM(2010)Chemoembolization for hepatocellular carcinoma: analysis in a 172-patient cohort Radiology 255 955-965
[3]
Bruix J(2002)Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Lancet 359 1734-1739
[4]
Kramer BS(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology. 35 1164-1171
[5]
Lencioni R(2003)Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology. 37 429-442
[6]
Zhu AX(2008)Sorafenib in advanced hepatocellular carcinoma N Engl J Med. 359 378-390
[7]
Lewandowski RJ(2010)The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma J Vasc Interv Radiol 21 1197-1204
[8]
Mulcahy MF(2011)Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times Gastroenterology 141 526-535
[9]
Kulik LM(2009)Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation Clin Transplant 23 874-881
[10]
Ryu RK(2004)Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology 40 1352-1360